Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 110 results for "Chronic Lymphocytic Leukemia (CLL)".

Thumbnail for Application of CRISPR-Cas9 Technology in the Treatment of Chronic Lymphocytic Leukemia with P53 Gene Mutations

CLL - 009

Application of CRISPR-Cas9 Technology in the Treatment of Chronic Lymphocytic Leukemia with P53 Gene Mutations

Aurelian Udristioiu

Poster Presenter: Aurelian Udristioiu

Thumbnail for Abnormal Apoptosis of Autoimmunity From Chronic Lymphocytic Leukemia

CLL - 010

Abnormal Apoptosis of Autoimmunity From Chronic Lymphocytic Leukemia

Aurelian Udristioiu

Poster Presenter: Aurelian Udristioiu

Thumbnail for Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017-2021)

Previous 1 2 3 4...13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

CLL - 046

Predictors and Outcomes of Major Cardiovascular Events in Hospitalized Chronic Lymphocytic Leukemia Patients (2017-2021)

Toluwani Balogun

Poster Presenter: Toluwani Balogun

Thumbnail for Frequency of Chromosome 11q22-q23 Deletion in Pakistani Patients With Chronic Lymphocytic Leukemia: A Single-Center Institutional Study

CLL - 065

Frequency of Chromosome 11q22-q23 Deletion in Pakistani Patients With Chronic Lymphocytic Leukemia: A Single-Center Institutional Study

Shayan Ashfaq

Poster Presenter: Shayan Ashfaq

Thumbnail for Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Predict Response, Minimal Residual Disease, and Survival and Guide Treatment Choice in Newly Diagnosed Chronic Lymphocytic Leukemia Patients

CLL - 074

Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Predict Response, Minimal Residual Disease, and Survival and Guide Treatment Choice in Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Omar Ali Elbaioumi

Poster Presenter: Omar Ali Elbaioumi

Thumbnail for Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

CLL - 083

Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

CLL - 1019

Real-World Safety Comparison of BTK Inhibitors in Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis of Acalabrutinib, Ibrutinib, and Zanubrutinib

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

CLL - 1026

Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

Chinenye Okafor

Poster Presenter: Chinenye Okafor

$Thumbnail for Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis$

CLL - 1061

Zanubrutinib Demonstrates Superior Outcomes Over Ibrutinib and Acalabrutinib in High-Risk Relapsed/Refractory CLL: A PRISMA-Based Systematic Review and Meta-Analysis

Subodh Mathew

Poster Presenter: Subodh Mathew

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors